J Pris

1.7k total citations
79 papers, 1.3k citations indexed

About

J Pris is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, J Pris has authored 79 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 25 papers in Genetics and 22 papers in Oncology. Recurrent topics in J Pris's work include Chronic Myeloid Leukemia Treatments (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers) and Acute Myeloid Leukemia Research (12 papers). J Pris is often cited by papers focused on Chronic Myeloid Leukemia Treatments (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers) and Acute Myeloid Leukemia Research (12 papers). J Pris collaborates with scholars based in France and United States. J Pris's co-authors include D Schlaifer, G. Laurent, Michel Attal, Pierre Brousset, Georges Delsol, B Boneu, J Corberand, C. Caranobe, Piérre Siè and Françoise Huguet and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Oncology.

In The Last Decade

J Pris

78 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Pris France 22 571 424 345 266 243 79 1.3k
M. J. Barnett Canada 20 676 1.2× 388 0.9× 243 0.7× 220 0.8× 173 0.7× 43 1.3k
Gunnar Grimfors Sweden 19 751 1.3× 405 1.0× 407 1.2× 350 1.3× 252 1.0× 41 1.4k
Y Carcassonne France 17 399 0.7× 278 0.7× 189 0.5× 174 0.7× 179 0.7× 115 1.1k
N Philippe France 18 456 0.8× 220 0.5× 266 0.8× 161 0.6× 255 1.0× 59 1.4k
Mauro Fiacchini Italy 22 966 1.7× 398 0.9× 497 1.4× 411 1.5× 454 1.9× 57 1.5k
MR O’Donnell United States 16 982 1.7× 358 0.8× 208 0.6× 234 0.9× 107 0.4× 25 1.4k
H. Wandt Germany 21 683 1.2× 596 1.4× 382 1.1× 495 1.9× 262 1.1× 48 1.9k
K. B. McCredie United States 22 1.1k 2.0× 444 1.0× 439 1.3× 116 0.4× 329 1.4× 52 1.7k
P. Meusers Germany 18 519 0.9× 689 1.6× 386 1.1× 648 2.4× 201 0.8× 43 1.5k
H Demuynck Belgium 16 884 1.5× 484 1.1× 297 0.9× 204 0.8× 160 0.7× 39 1.5k

Countries citing papers authored by J Pris

Since Specialization
Citations

This map shows the geographic impact of J Pris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Pris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Pris more than expected).

Fields of papers citing papers by J Pris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Pris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Pris. The network helps show where J Pris may publish in the future.

Co-authorship network of co-authors of J Pris

This figure shows the co-authorship network connecting the top 25 collaborators of J Pris. A scholar is included among the top collaborators of J Pris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Pris. J Pris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berry, Antoine, Muriel Alvarez, Françoise Huguet, et al.. (2005). Acute Plasmodium falciparum Malaria Following Splenectomy for Suspected Lymphoma in 2 Patients. Clinical Infectious Diseases. 40(11). e97–e100. 27 indexed citations
2.
Astudillo, L., F Loche, Emma Reynish, et al.. (2002). Sweet's syndrome associated with retinoic acid syndrome in a patient with promyelocytic leukemia. Annals of Hematology. 81(2). 111–114. 27 indexed citations
3.
Sailler, L., Éliane Duchayne, B. Marchou, et al.. (1997). Aspects étiologiques des hémophagocytoses réactionnelles: étude rétrospective chez 99 patients. La Revue de Médecine Interne. 18(11). 855–864. 45 indexed citations
4.
Schlaifer, D, Stanisław Krajewski, Françoise Rigal‐Huguet, et al.. (1996). Bcl-x Gene Expression in Hodgkin's Disease. Leukemia & lymphoma. 23(1-2). 143–146. 13 indexed citations
5.
Gopas, Jacob, Isebrand Prinsloo, J Pris, et al.. (1996). Frequent expression of the cell death-inducing gene Bax in Reed- Sternberg cells of Hodgkin's disease. Blood. 87(6). 2470–2475. 51 indexed citations
6.
Attal, Michel, Pierre Canal, D Schlaifer, et al.. (1994). Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in patients with refractory lymphoma undergoing autologous bone marrow transplantation.. Journal of Clinical Oncology. 12(1). 141–148. 30 indexed citations
7.
Schlaifer, D, Pierre Brousset, Michel Attal, et al.. (1994). bcl‐2 proto‐oncogene and Epstein–Barr virus latent membrane protein‐1 expression in AIDS‐related lymphoma. Histopathology. 25(1). 77–82. 13 indexed citations
8.
Attal, Michel, D Schlaifer, Jean-Paul Charlet, et al.. (1991). Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial.. Journal of Clinical Oncology. 9(5). 865–870. 52 indexed citations
9.
Broustet, A, Josy Reiffers, Gérald Marit, et al.. (1991). Hydroxyurea versus interferon alfa-2b in chronic myelogenous leukaemia: Preliminary results of an open French multicentre randomized study. European Journal of Cancer and Clinical Oncology. 27. S18–S21. 10 indexed citations
10.
Assoun, J, C Poëy, Michel Attal, et al.. (1991). [Magnetic resonance imaging in the bone sites of malignant non-Hodgkin's lymphoma. Apropos of 16 cases].. PubMed. 34(6-7). 383–6, 389. 1 indexed citations
11.
Attal, Michel, Françoise Huguet, D Schlaifer, et al.. (1991). Maintenance treatment with recombinant alpha interferon after autologous bone marrow transplantation for aggressive myeloma in first remission after conventional induction chemotherapy.. PubMed. 8(2). 125–8. 18 indexed citations
12.
Dastugue, Nicole, J Pris, & P Colombiès. (1990). Translocation t(3;21)(q26;q22) in acute myeloblastic leukemia secondary to polycythemia vera. Cancer Genetics and Cytogenetics. 44(2). 275–276. 18 indexed citations
13.
Harousseau, Jean‐Luc, et al.. (1989). Treatment of acute myeloid leukemia in elderly patients with oral idarubicin as a single agent. European Journal Of Haematology. 42(2). 182–185. 32 indexed citations
14.
Robert, Jacques, Françoise Rigal‐Huguet, J L Harousseau, et al.. (1987). Pharmacokinetics of idarubicin after daily intravenous administration in leukemic patients. Leukemia Research. 11(11). 961–964. 13 indexed citations
15.
Laurent, G., et al.. (1983). Manifestations méningo-encéphaliques et choriorétiniennes de la toxoplasmose chez un malade immuno-déprimé.. 59(1). 1 indexed citations
16.
Saal, F, F. Cavalièri, Marc Sitbon, & J Pris. (1983). Baboon Endogenous C type Virus induces syncytium formation in Epstein Barr Virus (EBV) carrying lymphoblastoid human cell lines. Archives of Virology. 75(1-2). 151–155. 3 indexed citations
17.
Caranobe, C., Piérre Siè, C. Nouvel, et al.. (1980). Platelets in myeloproliferative disorders. II. Serotonin uptake and storage: correlations with mepacrine labelled dense bodies and with platelet density.. PubMed. 25(4). 289–95. 20 indexed citations
18.
Fabre, John W., et al.. (1974). [Study of liver biopsies by "hairy cell leukemia" (author's transl)].. PubMed. 15(2). 139–56. 5 indexed citations
19.
Fabré, J, et al.. (1974). Etude des lésions hépatiques de la «Hairy Cell Leukemia». Virchows Archiv B Cell Pathology. 15(1). 7 indexed citations
20.
Corberand, J, et al.. (1973). [Aberrant erythrocyte indices provided by the model S Coulter Couter in patients with cold agglutinins].. PubMed. 21(5). 549–53. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. J. Barnett Breakdown of academic impact, for papers by Gunnar Grimfors Breakdown of academic impact, for papers by Y Carcassonne Breakdown of academic impact, for papers by N Philippe Breakdown of academic impact, for papers by Mauro Fiacchini Breakdown of academic impact, for papers by MR O’Donnell Breakdown of academic impact, for papers by H. Wandt Breakdown of academic impact, for papers by K. B. McCredie Breakdown of academic impact, for papers by P. Meusers Breakdown of academic impact, for papers by H Demuynck
Rankless by CCL
2026